Antibacterial, kinetics and bacteriolytic properties of silver(I) pyridinedicarboxylate compounds
Author
dc.contributor.author
Azócar, M. Ignacio
Author
dc.contributor.author
Gómez, Grace
es_CL
Author
dc.contributor.author
Velásquez, Carla
es_CL
Author
dc.contributor.author
Abarca, Romina
es_CL
Author
dc.contributor.author
Kogan Bocian, Marcelo
es_CL
Author
dc.contributor.author
Páez, Maritza
es_CL
Admission date
dc.date.accessioned
2014-12-11T18:41:05Z
Available date
dc.date.available
2014-12-11T18:41:05Z
Publication date
dc.date.issued
2014
Cita de ítem
dc.identifier.citation
Materials Science and Engineering C 37 (2014) 356–362
en_US
Identifier
dc.identifier.other
DOI: 10.1016/j.msec.2014.01.033
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/121885
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
Antibacterial properties of silver(I)-pyridinedicarboxylate compounds (with Pyridine-2,3-dicarboxylic(Lutidinic
acid), pyridine-2,4-dicarboxylic (Quinolinic acid) and pyridine-2,5-dicarboxylic (Isocinchomeronic acid)) were
studied against Escherichia coli, Listeria monocytogenes (ISP-65-08), Salmonella typhi and Staphylococcus aureus
(ATCC 25923) using kinetics of grown inhibition, viability assays, minimuminhibitory concentration and optical
microscopy. The 3 silver compounds were tested toward UV-radiation in order to characterize their light insensitivity
for potential medical devices: UV-radiation curable polymers. Photophysical measurements show
remarkable differences toward UV-radiation, which were explained based on their polymeric structures with
multiple nature bonds between pyridinedicarboxylic ligands and Ag(I) centers. We found a bacteriolytic effect
and differences in the antibacterial efficiency depending on the structure of the complexes and the nature of
Ag\X (X = oxygen and nitrogen) bonds: AgQuinol N AgLutidin N AgIsocinchom.
en_US
Patrocinador
dc.description.sponsorship
This work was supported by FONDECYT (Grant Nos 11080133 and
1100537), CONICYT (Grant: 79090024) FONDAP 15130011 and DICYT
(No 021340AG).